Amgen is asked about rebates
- Share via
Sen. Charles E. Grassley (R-Iowa) said he had asked Amgen Inc. to “account for notably high rebates” the company had offered physicians for prescribing Aranesp, an anemia drug.
Thousand Oaks-based Amgen paid almost $800 million in rebates to 6,000 facilities, including physician groups, in 2006, Grassley said, citing company data. Doctors collected payments from Medicare and insurers that exceeded the price they paid for the drugs, he said.
An Amgen spokeswoman said the company provided rebates, like many of its competitors, to its customers.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.